- Published at
- by manilatimes.net
positive
positive
Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
- IzoView positioned to disrupt high-growth breast imaging markets with target device price of USD $500K
News for Izotropic Corporation (IZO.CN)
- Published at
- by gurufocus.com
positivepositiveIzotropic Prepares New Platforms to Educate and Engage | IZOZF Stock News
Izotropic (OTCQB: IZOZF) initiates strategic awareness initiatives for IzoView Breast CT Imaging System commercialization. Launch of an awareness campai- Published at
- by gurufocus.com
positivepositiveIzotropic Revises License Agreement with The Regents of the University of California | IZOZF Stock News
Izotropic Corporation (IZO) revises global license agreement with UC Davis for breast cancer imaging technology. The amendment requires FDA approval or- Published at
- by gurufocus.com
positivepositiveIzotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update | IZOZF Stock News
Izotropic Corporation (IZOZF) secures FDA alignment for IzoView Breast CT Imaging System. Completed a 150-page strategic business plan and advanced fina- Published at
- by markets.businessinsider.com
neutralneutralLife Science Virtual Investor Forum: Presentations Now Available for Online Viewing
NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced t...- Published at
- by gurufocus.com
positivepositiveIzotropic to Present at Investor Conference February 6th
- CEO to present overview of Company value proposition, unique catalysts, and near-term objectives - - Event includes live Q and A, attendance is c- Published at
- by manilatimes.net
positivepositive- Published at
- by marketscreener.com
positivepositiveIzotropic Provides Regulatory and Operational Updates
Izotropic Corporation , a medical device company commercializing IzoView, a CT imaging system, that produces images of anatomy for non-invasive characterization of tissue with an application in...- Published at
- by prnewswire.com
mixedmixedBreast Cancer Diagnostics Global Market Report 2023: Industry to Reach $6.16 Billion by 2027 at a 6.67% CAGR
/PRNewswire/ -- The "Breast Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast - 2027" report has been added to ResearchAndMarkets....- Published at
- by prnewswire.com
neutralneutral- Published at
- by etfdailynews.com
neutralneutralIzotropic (OTCMKTS:IZOZF) Trading Down 5.9%
Read Izotropic (OTCMKTS:IZOZF) Trading Down 5.9% at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveIzotropic (OTCMKTS:IZOZF) Trading 10.1% Higher
Read Izotropic (OTCMKTS:IZOZF) Trading 10.1% Higher at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveIzotropic Co. (OTCMKTS:IZOZF) Short Interest Up 39.7% in May
Read Izotropic Co. (OTCMKTS:IZOZF) Short Interest Up 39.7% in May at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveIzotropic Co. (OTCMKTS:IZOZF) Short Interest Update
Read Izotropic Co. (OTCMKTS:IZOZF) Short Interest Update at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveIzotropic Co. (OTCMKTS:IZOZF) Sees Large Decline in Short Interest
Read Izotropic Co. (OTCMKTS:IZOZF) Sees Large Decline in Short Interest at ETF Daily News